Trial Profile

Phase 2a trial of AT-004

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 18 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Feb 2026 According to Arctic Therapeutics, the company announced that the first patients have been enrolled.
11 Feb 2026 According to Arctic Therapeutics, the study will be conducted across three clinical sites in Denmark and is being carried out by Blueskin, a leading European contract research organization (CRO) specializing in dermatology.
11 Feb 2026 According to Arctic Therapeutics, the study follows regulatory approval from the European Medicines Agency (EMA) in December 2025 and is conducted across three clinical sites in Denmark.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com